高级检索
    刘开彦, 陈奋, 翁建宇. PETHEMA ALL-93研究结果:成人高危急性淋巴细胞白血病缓解后维持治疗、异基因和自体造血干细胞移植的疗效比较[J]. 循证医学, 2007, 7(4): 196-199. DOI: 10.3969/j.issn.1671-5144.2007.04.002
    引用本文: 刘开彦, 陈奋, 翁建宇. PETHEMA ALL-93研究结果:成人高危急性淋巴细胞白血病缓解后维持治疗、异基因和自体造血干细胞移植的疗效比较[J]. 循证医学, 2007, 7(4): 196-199. DOI: 10.3969/j.issn.1671-5144.2007.04.002
    shu
    LIU Kai-yan, CHEN Fen, WENG Jian-yu. Comparison of Intensive Chemotherapy, Allogeneic or Autologous Stem Cell Transplantation as Post-Remission Treatment for Adult Patients with High-Risk Acute Lymphoblastic Leukemia. Results of the PETHEMA ALL-93 Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(4): 196-199. DOI: 10.3969/j.issn.1671-5144.2007.04.002
    Citation: LIU Kai-yan, CHEN Fen, WENG Jian-yu. Comparison of Intensive Chemotherapy, Allogeneic or Autologous Stem Cell Transplantation as Post-Remission Treatment for Adult Patients with High-Risk Acute Lymphoblastic Leukemia. Results of the PETHEMA ALL-93 Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(4): 196-199. DOI: 10.3969/j.issn.1671-5144.2007.04.002
    shu

    PETHEMA ALL-93研究结果:成人高危急性淋巴细胞白血病缓解后维持治疗、异基因和自体造血干细胞移植的疗效比较

    Comparison of Intensive Chemotherapy, Allogeneic or Autologous Stem Cell Transplantation as Post-Remission Treatment for Adult Patients with High-Risk Acute Lymphoblastic Leukemia. Results of the PETHEMA ALL-93 Trial

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回